Literature DB >> 12515931

[Amniotic membrane transplantation in severe corneal epithelial diseases. Preliminary results].

E Zito1, V Borderie, O Touzeau, T Bourcier, C Allouch, L Laroche.   

Abstract

PURPOSE: To evaluate amniotic membrane transplantation (AMT) in severe corneal epithelial diseases.
METHODS: Amniotic membrane transplantation was performed in 14 eyes of 14 patients from four groups: A, five severe ocular burns; B, four cases of cicatricial keratoconjunctivitis; C, three persistent epithelial defects after penetrating keratoplasty; D, two cases of pseudophakic bullous keratopathy. Five patients underwent AMT alone; two patients underwent AMT combined with limbal transplantation; the other three patients had limbal transplantation performed before AMT. Eight patients required combined penetrating keratoplasty. Patients with corneal stable reepithelialization, no corneal neovascularization, and no recurrence of the initial pathology were considered successful.
RESULTS: The mean follow-up was 7+/-3 months. All but three patients underwent corneal reepithelialization within 6 weeks of AMT, with a mean healing time of 31+/-23 days. The success rate was 75% at 6 months (Kaplan-Meier method). Three of four procedures in group B failed. In eight patients, visual acuity improved, in one it worsened, and in the last five patients it remained unchanged. Visual acuity increased by an average of 7+/-9 lines.
CONCLUSION: AMT is a useful technique for ocular surface reconstruction, especially in association with limbal transplantation. It could also improve the prognosis of penetrating keratoplasty in patients with severe corneal conditions.

Entities:  

Mesh:

Year:  2002        PMID: 12515931

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  The use of impression cytology in the follow-up of severe ocular burns.

Authors:  Jean-Jacques Gicquel; Renaud Navarre; Maria Elena Langman; Alix Coulon; Stephanie Balayre; Serge Milin; Martial Mercie; Alexis Rossignol; Anne Barra; Pierre-Marie Levillain; Jean-Marc Gombert; Paul Dighiero
Journal:  Br J Ophthalmol       Date:  2007-04-30       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.